Home Healthcare Medical Devices Veterinary CROs Market to 2027

Veterinary CROs Market to 2027

Publisher: The Insight Partners
Publication Date: January, 2020
Healthcare / Medical Devices
Pages: 150
Delivery Format: PDF

Global Analysis and Forecasts By Service Type (Clinical Trials, Toxicology, Market Authorization and Regulatory Support, Others); Application (Pet, Livestock, Wild); Indication (Oncology, Infectious Diseases, Neurology, Others); End-User (Animal Husbandry, Others) and Geography

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The global veterinary CROs market is expected to reach US$ 1,440.15 Mn in 2027 from US$ 710.81 Mn in 2019. The market is estimated to grow with a CAGR of 9.3% from 2019-2027.
Driving factors of the veterinary CROs are increasing demand for high performance materials and increasing funding by private bodies in R&D. Also, increasing Prevalence of veterinary diseases is likely to have a positive impact on the growth of the market in the coming years. Besides, development opportunities in emerging countries is expected to have a positive effect on the growth of the market in the forecast years.
In order to increase research and development activities, various public and private agencies or organizations are providing funds to the researchers to meet the increasing demand for technical innovation in several countries across the world. Several research activities are carried out by the biopharmaceutical companies and pharmaceutical companies to intensify the preference for rising Biosimilar and Veterinary Vaccines Market to boost the market growth in the upcoming years.
For instance, in April 2019, Charles River acquired Citoxlab is a premier, non-clinical contract research organization (CRO). This acquisition will provide the drug discovery and development continuum of drug. This will lead to enhance the veterinary data safety business.
Thus, the increasing initiatives and funds incurred by private or public organizations are expected to drive the growth of veterinary CROs, thereby propelling the growth of the market over the forecast years.
The global veterinary CROs is segmented by service type, application, indication, end-user. Based on the service type, the market is segmented into Clinical Trials, Toxicology, Market Authorization and Regulatory Support, Others. The clinical Trials segment is expected to dominate the service type segment market due to the benefits offered by clinical Trials over Toxicology and Market Authorization. Based on the application, the market is segmented into Pet, Livestock, Wild. The pet segment held the largest share of the application segment during the forecast period. Similarly, based on the indication, the veterinary CROs is categorized as oncology, infectious diseases, neurology, Others. The oncology held the largest share of the indication segment during the forecast period. Based on the end user, the veterinary CROs is categorized as biopharmaceutical companies, others. The biopharmaceutical companies segment held the largest share of the application segment during the forecast period
Some of the essential primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), World Bank, Emirates Development Bank, among others.

Reasons to buy this report:
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Veterinary CROs market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global Veterinary CROs market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Select Plan

1 User License $4,550

Site License License $6,550

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$4,550

Veterinary CROs Market to 2027

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed